About Revolution Medicines, Inc.

Revolution Medicines, Inc. (NASDAQ: RVMD) is a Healthcare company (Biotechnology) with a market capitalization of $41.6B. Its Maz Rating is 2.93 out of 5 (C+, Hold), ranked against the other companies in its sector.

Factor scores: Valuation 1.57, Growth 2.62, Profitability 2.02, Financial Health 3.09, Momentum 4.37 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

Mark A. Goldsmith

Employees

883

IPO date

2020-02-13